{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:21:17Z","timestamp":1792228877173,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2963,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/modpathol.2014.71","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T08:15:05Z","timestamp":1398413705000},"page":"1621-1631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH"],"prefix":"10.1016","volume":"27","author":[{"given":"Prudence A","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Conron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Wainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin M","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2014.71_bib1","unstructured":"Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2012. Cancer in Australia: An Overview . Cancer Series No. 74. Cat. No. CAN 70. AIHW: Canberra, 2012."},{"key":"10.1038\/modpathol.2014.71_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2014.71_bib3","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2014.71_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefinitib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomized phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2014.71_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomized phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2014.71_bib6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2011.36.8456","article-title":"First-SIGNAL: first-line single-agent Iressa Versus Gemcitabine and Cisplatin Trial in never-smokers with adenocarcinoma of the lung","volume":"30","author":"Han","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2014.71_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomized phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2014.71_bib8","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2014.71_bib9","first-page":"62ra93","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"15","author":"Weiss","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1038\/modpathol.2014.71_bib10","doi-asserted-by":"crossref","first-page":"e20351","DOI":"10.1371\/journal.pone.0020351","article-title":"Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer","volume":"6","author":"Dutt","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1038\/modpathol.2014.71_bib11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ng.465","article-title":"SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas","volume":"41","author":"Bass","year":"2009","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2014.71_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2010","journal-title":"J Biochem"},{"key":"10.1038\/modpathol.2014.71_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2014.71_bib14","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-11-0699","article-title":"Molecular pathways: Fibroblast growth factor signalling \u2013 a new therapeutic opportunity in cancer","volume":"18","author":"Brooks","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2014.71_bib15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.oraloncology.2013.01.006","article-title":"Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome","volume":"49","author":"Young","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1038\/modpathol.2014.71_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0006-291X(02)00836-7","article-title":"Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH","volume":"296","author":"Ishizuka","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/modpathol.2014.71_bib17","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1158\/1078-0432.CCR-07-0502","article-title":"High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications","volume":"13","author":"Gorringe","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2014.71_bib18","first-page":"4514","article-title":"High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer","volume":"61","author":"Simon","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2014.71_bib19","first-page":"5271","article-title":"Gene amplifications associated with the development of hormone-resistant prostate cancer","volume":"9","author":"Edwards","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2014.71_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/gcc.20655","article-title":"Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development","volume":"48","author":"Missiaglia","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2014.71_bib21","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/JTO.0b013e31826aed28","article-title":"FGFR1 amplification in squamous cell carcinoma of the lung","volume":"7","author":"Heist","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2014.71_bib22","first-page":"73","article-title":"Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer","volume":"31","author":"Kim","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2014.71_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.lungcan.2013.05.015","article-title":"Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer","volume":"81","author":"Tran","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1038\/modpathol.2014.71_bib24","first-page":"725","article-title":"Increased FGFR1 copy number in lung squamous cell carcinomas","volume":"5","author":"Sasaki","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1038\/modpathol.2014.71_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00428-012-1250-y","article-title":"FGFR1 expression and gene copy numbers in human lung cancer","volume":"461","author":"Kohler","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2014.71_bib26","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/modpathol.2012.102","article-title":"Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer","volume":"25","author":"Schildhaus","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2014.71_bib27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1378\/chest.11-2943","article-title":"Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors","volume":"142","author":"G\u00f6ke","year":"2012","journal-title":"Chest"},{"key":"10.1038\/modpathol.2014.71_bib28","unstructured":"Travis WD, Brambilla E . Chapter 1. Tumours of the lung In: Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds). Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and HeartWorld Health Organisation Classification of Tumours. IARC Press: Lyon, 2004, pp 26\u201362."},{"key":"10.1038\/modpathol.2014.71_bib29","series-title":"International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology","first-page":"67","article-title":"Chapter 5. Site-specific explanatory notes for lung and pleural tumours","author":"Goldstraw","year":"2009"},{"key":"10.1038\/modpathol.2014.71_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"The new IASLC\/ATS\/ERS international multidisciplinary lung adenocarcinoma classification","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2014.71_bib31","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/JTO.0b013e31818e0d9f","article-title":"Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2014.71_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.2012.195","article-title":"Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma","volume":"26","author":"Rekhtman","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2014.71_bib33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/modpathol.2011.92","article-title":"Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens","volume":"24","author":"Rekhtman","year":"2011","journal-title":"Mod Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201471","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:12:02Z","timestamp":1760231522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222035281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0893395222035281"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2014.71","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2014.71","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}